Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U ‐100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring

ConclusionsA TIR of>70% was achieved for both fixed-ratio combinations without significant differences.

Source: Journal of Diabetes Investigation - January 23, 2024 Category: Endocrinology Authors: Yuji Kawaguchi, Yuriko Hajika, Maho Rinka, Koji Masumoto, Jun Sawa, Kenji Hamazaki, Yasuro Kumeda Tags: Original Article Source Type: research